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Although large observational studies demonstrate an association between presence of 
atypical naevi and melanoma risk, the actual benefit of dermatological surveillance for 
patients with multiple atypical naevi is less clear.1,2 Therefore recommendations for 
surveillance of such patients vary between countries. The UK guideline for the management 
of cutaneous melanoma recommends that such patients should be taught how to self-
examine for changing naevi.3 A survey among dermatologists from the US revealed that 59% 
recommend annual screening for patients with atypical naevi.4 In the Netherlands, patients 
with 5 or more atypical naevi commonly undergo long-term yearly surveillance by a 
dermatologist in addition to receiving skin self-examination instructions.5 Here we examined 
the diagnosis of melanoma during periodic surveillance of Dutch patients with multiple 
atypical naevi and analyzed the clinical characteristics of the subset of patients with atypical 
naevi who developed melanoma. All patients with 5 or more clinically atypical naevi, based 
on ABCD-criteria, and patients with more than 100 common naevi (collectively referred to as 
AN patients here) are seen for yearly dermatological consultation and for unscheduled visits 
when patients would notice suspicious lesions at the dermatology department of Leiden 
University Medical Center. We performed a cohort analysis on 1131 AN patients (641 
women, 493 men, mean age 41 years) who visited our department between 2011 and 2016 
for periodic surveillance consisting of total skin examination with use of dermoscopy, and 
total body photography in a subset of patients. Patients with familial melanoma, recent 
melanoma diagnosis or other reasons for surveillance were excluded. During the follow-up 
period (total follow-up time 3268 years) melanoma was diagnosed in 39 patients, 17 women 
and 22 men at a mean age 48 years (range 22-58). The rate of incident melanoma was 1.1% 
per follow-up year. Nine patients developed multiple melanomas, resulting in a total of 56 
melanoma cases. There were 46 invasive melanomas and 10 in situ melanomas. Median 
Breslow thickness of the invasive melanomas was 0.67 mm (range 0,2 – 2,7 mm). The 
majority of melanomas was of the superficial spreading type (87%). Melanoma was detected 
by the dermatologist during routine follow-up examination in 79%, had been noted by the 
patient first in 18% and had been discovered by the general practitioner in 4% of cases. 
During the surveillance period 1550 skin lesions were excised, but in a proportion of cases 
for other reasons such as cosmetic concerns and basal cell carcinoma. Based on total body 
photographs and histopathology, a reliable conclusion could be drawn if the melanoma had 
originated from a precursor nevus or de novo from normal appearing skin in 22 cases. In 72% 
melanoma had developed from a atypical or common nevus, which is higher than reported 
for melanoma in the general population (29%).6  
Study of the clinical characteristics of AN patients who develop melanoma might 
enable more precise delineation of the patient group for whom surveillance would be most 
beneficial. To identify additional risk factors for melanoma we performed a case-control 
study on a largely unrelated cohort of 410 AN patients who had their first visit between 2011 
and 2016 and from whom we had collected detailed information on phenotypical risk factors 
for melanoma. The presence and absence of each clinical risk factor was compared among 
85 AN patients who had developed melanoma previously, at first visit or during periodic 
surveillance (cases) and 325 AN patients who never had developed melanoma (controls). 
The age- and sex-adjusted risk of melanoma was highest among AN patients with red hair 
(OR 4.8) or blond hair (OR 1.9), more than 100 solar lentigines (OR 3.4) and blistering 
sunburn during childhood (OR 1.6) (Table 1).   
Our results reinforce the notion that dermatological surveillance with periodic skin 
examination is beneficial and a justified strategy for early detection of melanoma in AN 
patients. Remarkably, most melanomas were diagnosed by the dermatologist during 
examination and had not been noticed by the patient in spite of skin self-examination 
instructions in the majority of cases. The modifying effects of skin phototype and ultraviolet 
radiation-induced damage on melanoma risk in AN patients point to the independence of 
pigmentation- and nevus-related factors in melanoma susceptibility. As AN patients with red 
or blond hair, solar lentigines or a history or sunburn during childhood are at highest risk of 
developing melanoma, regular surveillance of these patients seems of particular importance. 
Comprehensive assessment of the health benefits and costs of yearly follow-up of AN 
patients as compared to skin self-examination on a population-wide scale is required to 
formulate melanoma prevention strategies in this patient group at increased risk. 
 
  
References 
 
1. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous 
melanoma: I. Common and atypical naevi. Eur J Cancer 2005;41:28-44. 
2. de Snoo FA, Kroon MW, Bergman W et al. From sporadic atypical nevi to familial 
melanoma: risk analysis for melanoma in sporadic atypical nevus patients. J Am Acad 
Dermatol. 2007;56:748-752. 
3. Marsden JR, Newton-Bishop JA, Burrows L et al. Revised U.K. guidelines for the 
management of cutaneous melanoma 2010. Br J Dermatol. 2010;163:238-256. 
4. Tripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey 
of fellows of the American Academy of Dermatology. J Am Acad Dermatol. 
2002;46:674–682. 
5. Veerbeek L, Kruit WH, de Wilt J et al. Multidisciplinaire Richtlijnwerkgroep 
Melanoom. [Revision of the national guideline 'Melanoma']. Ned Tijdschr Geneeskd. 
2013;157:A6136.  
6. Pampena R, Kyrgidis A, Lallas A et al. A meta-analysis of nevus-associated melanoma: 
Prevalence and practical implications. J Am Acad Dermatol. 2017;77:938-945. 
  
 Table. Clinical risk factors for melanoma in AN patients
Overall Melanoma No Melanoma OR (CI 95%) OR (CI 95%) adjusted 
n= 410 n= 85 n= 325 for age and gender
Gender Female 241 45 196 Reference
Male 168 40 128 1.4 (0.8 - 2.2)
>100 common No 131 22 109 Reference Reference
naevi Yes 258 57 201 1.3 (0.8 - 2.4) 1.2 (0.7 - 2.2)
≥5 atypical naevi No 149 30 119 Reference Reference
Yes 225 46 179 1.0 (0.6 - 1.7) 1.0 (0.6 -1.8)
Skin type I 47 9 38 1.3 (0.5 - 3.8) 1.9 (0.6 - 5.8)
II 300 64 236 1.4 (0.6 - 3.1) 1.7 (0.7 - 3.9)
III-V 54 8 46 Reference Reference
Eye color Blue 244 60 184 1.8 (1.1 - 3.1) 1.7 (1.0-3.0)
Other 150 22 128 Reference Reference
Hair color Red or blond 20 6 14 2.2 (1.1-4.4) 2.8 (1.3-6.1)
Brown or black 375 75 300 Reference Reference
Sunbathing Never 160 33 127 Reference Reference
Ever 117 31 86 1.1 (0.7 - 1.9) 1.5 (0.9 - 2.7)
Sunbed use Never 302 72 230 Reference Reference
Ever 20 3 17 0.5 (0.2 - 1.3) 0.6 (0.3 - 1.3)
Blistering sunburn No 318 59 259 Reference Reference
<20yr Yes 80 19 61 1.7 (1.1 - 2.7) 1.6 (1.0 - 2.5)
Solar lentigines 0-40 288 45 243 Reference Reference
40-100 77 29 72 2.0 (1.4-3.1) 1.8 (1.2-2.8)
≥100 25 14 11 4.0 (1.7-9.7) 3.1 (1.2-7.8)
Actinic keratoses 0 353 64 289 Reference Reference
≥1 22 11 11 4.5 (1.8 - 10.7) 1.2 (0.4 - 3.5)
